Browse > Article
http://dx.doi.org/10.3904/kjim.2014.29.4.489

Ferritin as a predictor of decline in residual renal function in peritoneal dialysis patients  

Hur, Soon Mi (Division of Nephrology, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital)
Ju, Hye Young (Division of Nephrology, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital)
Park, Moo Yong (Division of Nephrology, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital)
Choi, Soo Jeong (Division of Nephrology, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital)
Kim, Jin Kuk (Division of Nephrology, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital)
Hwang, Seung Duk (Division of Nephrology, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital)
Publication Information
The Korean journal of internal medicine / v.29, no.4, 2014 , pp. 489-497 More about this Journal
Abstract
Background/Aims: Inflammation is an important factor in renal injury. Ferritin, an inflammatory marker, is considered an independent predictor of rapid renal progression in patients with chronic kidney disease. However, the relationship between ferritin and residual renal function (RRF) in patients undergoing peritoneal dialysis (PD) remains unclear. Methods: We reviewed the medical records of patients who started PD between June 2001 and March 2012 at Soonchunhyang University Bucheon Hospital, Korea. A total of 123 patients were enrolled in the study. At 1 month after the initiation of PD, RRF was determined by a 24-hour urine collection and measured every 6 months thereafter. Clinical and biochemical data at the time of the initial 24-hour urine collection were considered as baseline. Results: The RRF reduction rate was significantly greater in patients with high ferritin (ferritin ${\geq}250ng/mL$) compared with those with low ferritin (ferritin < 250 ng/mL;$-1.71{pm}1.36mL$/min/yr/$1.73m^2$ vs. $-0.84{pm}1.63mL$/min/yr/$1.73m^2$, respectively; p = 0.007). Pearson correlation analysis revealed a significant negative correlation between the baseline serum ferritin level and the RRF reduction rate (r = -0.219, p = 0.015). Using multiple linear regression analysis and adjusting for other risk factors, baseline serum ferritin was an independent factor for the RRF reduction rate (${\beta}$ = -0.002, p = 0.002). Conclusions: In this study we showed that a higher ferritin level was significantly associated with a more rapid RRF decline in patients undergoing PD.
Keywords
Ferritins; Peritoneal dialysis; Residual renal function;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Bargman JM, Golper TA. The importance of residual renal function for patients on dialysis. Nephrol Dial Transplant 2005;20:671-673.   DOI   ScienceOn
2 Moist LM, Port FK, Orzol SM, et al. Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol 2000;11:556-564.
3 Kim SG, Kim NH. The effect of residual renal function at the initiation of dialysis on patient survival. Korean J Intern Med 2009;24:55-62.   DOI   ScienceOn
4 Singhal MK, Bhaskaran S, Vidgen E, Bargman JM, Vas SI, Oreopoulos DG. Rate of decline of residual renal function in patients on continuous peritoneal dialysis and factors affecting it. Perit Dial Int 2000;20:429-438.
5 Liao CT, Shiao CC, Huang JW, et al. Predictors of faster decline of residual renal function in Taiwanese peritoneal dialysis patients. Perit Dial Int 2008;28 Suppl 3:S191-S195.
6 Rifkin DE, Sarnak MJ. Does inflammation fuel the fire in CKD? Am J Kidney Dis 2009;53:572-575.   DOI   ScienceOn
7 Kalantar-Zadeh K, Rodriguez RA, Humphreys MH. Association between serum ferritin and measures of inflammation, nutrition and iron in haemodialysis patients. Nephrol Dial Transplant 2004;19:141-149.   DOI   ScienceOn
8 Qureshi AR, Alvestrand A, Divino-Filho JC, et al. Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients. J Am Soc Nephrol 2002;13 Suppl 1:S28-S36.
9 Kalantar-Zadeh K, Ikizler TA, Block G, Avram MM, Kopple JD. Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. Am J Kidney Dis 2003;42:864-881.   DOI   ScienceOn
10 Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340:448-454.   DOI   ScienceOn
11 Kalantar-Zadeh K, Don BR, Rodriguez RA, Humphreys MH. Serum ferritin is a marker of morbidity and mortality in hemodialysis patients. Am J Kidney Dis 2001;37:564-   DOI   ScienceOn
12 Tsai YC, Hung CC, Kuo MC, et al. Association of hsCRP, white blood cell count and ferritin with renal outcome in chronic kidney disease patients. PLoS One 2012;7:e52775.   DOI
13 Hasuike Y, Nonoguchi H, Tokuyama M, et al. Serum ferritin predicts prognosis in hemodialysis patients: the Nishinomiya study. Clin Exp Nephrol 2010;14:349-355.   DOI
14 Kovesdy CP, Estrada W, Ahmadzadeh S, Kalantar-Zadeh K. Association of markers of iron stores with outcomes in patients with nondialysis-dependent chronic kidney disease. Clin J Am Soc Nephrol 2009;4:435-441.   DOI   ScienceOn
15 Canada-USA (CANUSA) Peritoneal Dialysis Study Group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. J Am Soc Nephrol 1996;7:198-207.
16 II. NKF-K/DOQI Clinical Practice Guidelines for Peritoneal Dialysis Adequacy: update 2000. Am J Kidney Dis 2001;37(1 Suppl 1):S65-S136.   DOI   ScienceOn
17 Rogers JT, Bridges KR, Durmowicz GP, Glass J, Auron PE, Munro HN. Translational control during the acute phase response: ferritin synthesis in response to interleukin-1. J Biol Chem 1990;265:14572-14578.
18 Krediet RT. How to preserve residual renal function in patients with chronic kidney disease and on dialysis? Nephrol Dial Transplant 2006;21 Suppl 2:ii42-ii46.   DOI
19 Paniagua R, Amato D, Vonesh E, et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 2002;13:1307-1320.
20 Bargman JM, Thorpe KE, Churchill DN; CANUSA Peritoneal Dialysis Study Group. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol 2001;12:2158-2162.
21 Jenq CC, Hsu CW, Huang WH, Chen KH, Lin JL, Lin-Tan DT. Serum ferritin levels predict all-cause and infection- cause 1-year mortality in diabetic patients on maintenance hemodialysis. Am J Med Sci 2009;337:188-194.   DOI   ScienceOn
22 Cavill I. Iron status as measured by serum ferritin: the marker and its limitations. Am J Kidney Dis 1999;34(4 Suppl 2):S12-S17.   DOI   ScienceOn
23 Kalantar-Zadeh K, Luft FC, Humphreys MH. Moderately high serum ferritin concentration is not a sign of iron overload in dialysis patients. Kidney Int 1999;56:758-759.   DOI   ScienceOn
24 Gunnell J, Yeun JY, Depner TA, Kaysen GA. Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis 1999;33:63-72.   DOI   ScienceOn
25 Worwood M. Ferritin. Blood Rev 1990;4:259-269.   DOI   ScienceOn
26 Kwak EL, Larochelle DA, Beaumont C, Torti SV, Torti FM. Role for NF-kappa B in the regulation of ferritin H by tumor necrosis factor-alpha. J Biol Chem 1995;270:15285-15293.   DOI   ScienceOn
27 Avramovski P, Janakievska P, Sotiroski K, Sikole A. Accelerated progression of arterial stiffness in dialysis patients compared with the general population. Korean J Intern Med 2013;28:464-474.   DOI   ScienceOn
28 Kalantar-Zadeh K, Hoffken B, Wunsch H, Fink H, Kleiner M, Luft FC. Diagnosis of iron deficiency anemia in renal failure patients during the post-erythropoietin era. Am J Kidney Dis 1995;26:292-299.   DOI   ScienceOn
29 Smith JE, Cipriano JE. Inflammation-induced changes in serum iron analytes and ceruloplasmin of Shetland ponies. Vet Pathol 1987;24:354-356.   DOI
30 Rosa NetoI NS, de CarvalhoII JF. The use of inflammatory laboratory tests in rheumatology. Bras J Rheumatol 2009;49:413-430.
31 Fogo AB. Mechanisms of progression of chronic kidney disease. Pediatr Nephrol 2007;22:2011-2022.   DOI   ScienceOn